Skip to main content
Published locations for Onartuzumab plus erlotinib extended overall survival in MET-positive lung cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Onartuzumab plus erlotinib extended overall survival in MET-positive lung cancer
User login
Username
Password
Reset your password
/content/onartuzumab-plus-erlotinib-extended-overall-survival-met-positive-lung-cancer
/oncologypractice/article/78742/lung-cancer/onartuzumab-plus-erlotinib-extended-overall-survival-met
/hematology-oncology/article/78742/lung-cancer/onartuzumab-plus-erlotinib-extended-overall-survival